{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:20:16Z","timestamp":1789993216505,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejmech.2023.115459","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T21:38:06Z","timestamp":1683236286000},"page":"115459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-4309","authenticated-orcid":false,"given":"Hui-Ju","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suddhasatwa","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Jung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-I","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Eight","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115459_bib1","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2023.115459_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2023.115459_bib3","article-title":"Novel therapies in glioblastoma","volume":"2012","author":"Perry","year":"2012","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.ejmech.2023.115459_bib4","first-page":"381","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2023.115459_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102883","article-title":"Novel treatment strategies for glioblastoma","volume":"12","author":"Stylli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2023.115459_bib6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-018-1927-8","article-title":"Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy","volume":"125","author":"Shih","year":"2018","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejmech.2023.115459_bib7","first-page":"125","article-title":"Special issue on monoamine oxidase A and B: eternally enigmatic isoenzymes","author":"Shih","year":"2018","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejmech.2023.115459_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40263-013-0097-3","article-title":"Current place of monoamine oxidase inhibitors in the treatment of depression","volume":"27","author":"Shulman","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2023.115459_bib9","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1172\/JCI70982","article-title":"Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis","volume":"124","author":"Wu","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2023.115459_bib10","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/ja512613j","article-title":"Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth","volume":"137","author":"Wu","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115459_bib11","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.18632\/oncotarget.7283","article-title":"Monoamine oxidase A (MAO A) inhibitors decrease glioma progression","volume":"7","author":"Kushal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2023.115459_bib12","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1111\/1759-7714.13617","article-title":"Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth","volume":"11","author":"Yang","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ejmech.2023.115459_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12906-020-03041-z","article-title":"PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma","volume":"20","author":"Li","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.ejmech.2023.115459_bib14","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1021\/acs.jmedchem.1c01726","article-title":"N-Methylpropargylamine-Conjugated hydroxamic acids as dual inhibitors of monoamine oxidase A and histone deacetylase for glioma treatment","volume":"65","author":"Mehndiratta","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib15","series-title":"Molecular Chaperones","first-page":"155","article-title":"Hsp90: structure and function","author":"Jackson","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115459_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115459_bib17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/07357900802087259","article-title":"Can the lack of HSP90alpha protein in brain normal tissue and cell lines, rationalise it as a possible therapeutic target for gliomas?","volume":"26","author":"Shervington","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ejmech.2023.115459_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11060-014-1579-y","article-title":"Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models","volume":"120","author":"Di","year":"2014","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2023.115459_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2008.10.005","article-title":"17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis","volume":"33","author":"Siegelin","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2023.115459_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1215\/15228517-2008-060","article-title":"Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells","volume":"11","author":"Sauvageot","year":"2009","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2023.115459_bib21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/cancers6021031","article-title":"An impermeant ganetespib analog inhibits extracellular hsp90-mediated cancer cell migration that involves lysyl oxidase 2-like protein","volume":"6","author":"McCready","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2023.115459_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1535-7163.MCT-09-0683","article-title":"Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma","volume":"9","author":"Gaspar","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2023.115459_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112652","article-title":"An insight on medicinal attributes of 1,2,4-triazoles","volume":"205","author":"Aggarwal","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib24","article-title":"Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity","volume":"1","author":"Barreca","year":"2021","journal-title":"Eur. J.Med. Chem.Rep"},{"key":"10.1016\/j.ejmech.2023.115459_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm701018h","article-title":"4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer","volume":"51","author":"Brough","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib26","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm401536b","article-title":"Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold","volume":"57","author":"Taddei","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib27","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib28","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1158\/1078-0432.CCR-11-2967","article-title":"Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer","volume":"18","author":"Shimamura","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115459_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.538663","article-title":"Multi-cell type glioblastoma tumor spheroids for evaluating sub-population-specific drug response","volume":"8","author":"Sivakumar","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.115459_bib30","article-title":"Cellular and molecular comparison of glioblastoma multiform cell lines","volume":"13","author":"Demircan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2023.115459_bib31","first-page":"349","article-title":"Characteristics of A172 and T98g cell lines","volume":"58","author":"Kiseleva","year":"2016","journal-title":"Tsitologiia"},{"key":"10.1016\/j.ejmech.2023.115459_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113338","article-title":"Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: a preliminary attempt to unravel the enigma of glioblastoma","volume":"217","author":"Nepali","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12929-022-00804-3","article-title":"Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation","volume":"29","author":"Tsai","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2023.115459_bib34","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/pro.3933","article-title":"Hsp90 chaperones have an energetic hot-spot for binding inhibitors","volume":"29","author":"Hoxie","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2023.115459_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104616","article-title":"Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors","volume":"107","author":"Delogu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib36","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B","volume":"102","author":"De Colibus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2023.115459_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/BMC.2011.030","article-title":"Structures and mechanism of the monoamine oxidase family","volume":"2","author":"Gaweska","year":"2011","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.ejmech.2023.115459_bib38","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2174\/138161211797249224","article-title":"Targeting the AKT pathway in glioblastoma","volume":"17","author":"McDowell","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2023.115459_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/75596","article-title":"Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice","volume":"25","author":"Holland","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2023.115459_bib40","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/s41388-018-0325-x","article-title":"Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate","volume":"37","author":"Liao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.115459_bib41","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3892\/or.2016.5088","article-title":"HER2-targeted recombinant protein immuno-caspase-6 effectively induces apoptosis in HER2-overexpressing GBM cells in vitro and in vivo","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2023.115459_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1078-0432.CCR-09-1322","article-title":"HER2-Specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors","volume":"16","author":"Ahmed","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115459_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/cc.3.1.607","article-title":"The Achilles heel of ErbB-2\/HER2 - regulation by the Hsp90 chaperone machine and potential for pharmacological intervention","volume":"3","author":"Citri","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2023.115459_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.phrs.2015.12.028","article-title":"Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain","volume":"104","author":"Thirstrup","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115459_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12974-018-1330-2","article-title":"The IFN-gamma\/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1\/PD-L1 therapy","volume":"15","author":"Qian","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2023.115459_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2023.115459_bib47","article-title":"Development of PD-1\/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer","volume":"5","author":"He","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115459_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chembiol.2020.10.005","article-title":"HSP90 inhibition enhances cancer immunotherapy by modulating the surface expression of multiple immune checkpoint proteins","volume":"28","author":"Zavareh","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ejmech.2023.115459_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2022.10.016","article-title":"Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression","volume":"634","author":"Lapierre","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115459_bib50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.redox.2017.08.005","article-title":"Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O(6)-methylguanine-DNA methyltransferase","volume":"13","author":"Chang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2023.115459_bib51","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.1074\/jbc.M410033200","article-title":"R1, a novel repressor of the human monoamine oxidase A","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111725","article-title":"N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-gamma induced PD-L1 expression","volume":"185","author":"Mehndiratta","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115459_bib53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.freeradbiomed.2021.06.028","article-title":"17beta-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma","volume":"172","author":"Lin","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115459_bib54","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115459_bib55","series-title":"Schr\u00f6dinger Release 2022-3","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115459_bib56","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:54:36Z","timestamp":1759330476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423004257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":56,"alternative-id":["S0223523423004257"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115459","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115459"}}